Back to dashboard
Traditional MedicareCoverageLow impact

MolDX: Decision Dx-UM (Uveal Melanoma)

Medicare/CMS - LCD·Ophthalmology, Oncology·Local Coverage Determination
Effective date
May 28, 2026
We identified it
Jun 17, 2026
Days to comply
—

Summary

This is a new Medicare Local Coverage Determination for Decision Dx-UM genetic testing for uveal melanoma, establishing coverage criteria and billing requirements for this specialized oncologic diagnostic test.

Action Required

Action needed
By May 28, 2026: Billing team should review the full LCD policy at the provided CMS URL to understand coverage criteria, documentation requirements, and billing guidelines for Decision Dx-UM uveal melanoma genetic testing. This primarily affects ophthalmology and oncology practices treating uveal melanoma patients.

Related policy hubs